Total serum IgE levels and atopic status in patients with sarcoidosis

Allergy and Asthma Proceedings

Volumn 33, Issue 1, 2012, Pages 90-94

  Hattori, Takeshi ^a   Konno, Satoshi ^a   Shigemura, Masahiko ^b   Matsuno, Kazuhiko ^b   Shimizu, Chikara ^b   Shigehara, Katsunori ^c   Shijubo, Noriharu ^c   Hizawa, Nobuyuki ^d   Yamaguchi, Etsuro ^e   Nishimura, Masaharu ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

^b HOKKAIDO UNIVERSITY HOSPITAL   (Japan)

^c Sapporo General Hospital of Hokkaido Railway Company   (Japan)

^d UNIVERSITY OF TSUKUBA   (Japan)

^e AICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN E;

ADULT; AGE; AGED; ARTICLE; ATOPY; CONTROLLED STUDY; DISEASE ACTIVITY; FEMALE; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; REMISSION; SARCOIDOSIS; SEX DIFFERENCE; SEX RATIO;

ADOLESCENT; ADULT; AGED; DISEASE PROGRESSION; EYE; FEMALE; HUMANS; HYPERSENSITIVITY; IMMUNOGLOBULIN E; LUNG; MALE; MIDDLE AGED; PREVALENCE; SARCOIDOSIS; YOUNG ADULT;

EID: 84857498722     PISSN: 10885412     EISSN: 15396304     Source Type: Journal    
DOI: 10.2500/aap.2012.33.3491     Document Type: Article

References (24)

1. Gerke AK, and Hunninghake G. The immunology of sarcoidosis. Clin Chest Med 29:379 -390, 2008.
2. Iannuzzi MC, Rybicki BA, and Teirstein AS. Sarcoidosis. N Engl J Med 357:2153-2165, 2007.
3. Reiner SL, and Seder RA. T helper cell differentiation in immune response. Curr Opin Immunol 7:360 -366, 1995.
4. Morel PA, and Oriss TB. Crossregulation between Th1 and Th2 cells. Crit Rev Immunol 18:275-303, 1998. (Pubitemid 28364148)
5. Hartung AD, Bohnert A, Hackstein H, et al. Th2-mediated atopic disease protection in Th1-mediated rheumatoid arthritis. Clin Exp Rheumatol 21:481- 484, 2003.
6. Kira J, Kawano Y, and Yamasaki K. Multiple sclerosis with mite antigen-specific IgE. J Neurol Sci 157:138 -142, 1998.
7. Yagura T, Shimizu M, Yamamura Y, et al. Serum IgE levels and reaginic-type skin reactions in sarcoidosis. Clin Exp Immunol 21:289 -297, 1975.
8. Kokturk N, Han ER, and Turktas H. Atopic status in patients with sarcoidosis. Allergy Asthma Proc 26:121-124, 2005. (Pubitemid 40770073)
9. Rybicki BA, Major M, Popovich J Jr, et al. Racial differences in sarcoidosis incidence: A 5-year study in a health maintenance organization. Am J Epidemiol 145:234 -241, 1997.
10. Krause T, Koch A, Friborg J, et al. Frequency of atopy in the Arctic in 1987 and 1998. Lancet 360:691- 692, 2002.
11. Hattori T, Konno S, Takahashi A, et al. The role of atopy in the clinical course of pulmonary sarcoidosis in the Japanese population. Allergy Asthma Proc 31:238 -243, 2010.
12. Hunninghake GW, Costabel U, Ando M, et al. ATS/ERS/ WASOG statement on sarcoidosis. American Thoracic Society/ European Respiratory Society/World Association of Sarcoidosis and other Granulomatous Disorders. Sarcoidosis Vasc Diffuse Lung Dis 16:149 -173, 1999.
13. Hattori T, Konno S, Takahashi A, et al. Genetic variants in mannose receptor gene (MRC1) confer susceptibility to increased risk of sarcoidosis. BMC Med Genet 11:151, 2010.
14. Hattori T, Konno S, Hizawa N, et al. Genetic variants in the mannose receptor gene (MRC1) are associated with asthma in two independent populations. Immunogenetics 61:731-738, 2009.
15. Isada A, Konno S, Hizawa N, et al. A functional polymorphism (-603A → G) in the tissue factor gene promoter is associated with adult-onset asthma. J Hum Genet 55:167-174, 2010.
16. Hizawa N, Yamaguchi E, Takahashi D, et al. Functional polymorphisms in the promoter region of macrophage migration inhibitory factor and atopy. Am J Respir Crit Care Med 169: 1014-1018, 2004. (Pubitemid 38543639)
17. Konno S, Hizawa N, Yamaguchi E, et al. (CCTTT)n repeat polymorphism in the NOS2 gene promoter is associated with atopy. J Allergy Clin Immunol 108:810-814, 2001. (Pubitemid 33096215)
18. Ihaka R, and Gentleman R. R: A language for data analysis and graphics. J Comp Graph Stat 5:299 -314, 1996.
19. Baldini M, Lohman IC, Halonen M, et al. A polymorphism*in the 5 ′ flanking region of the CD14 gene is associated with circulating soluble CD14 levels and with total serum immunoglobulin E. Am J Respir Cell Mol Biol 20:976 -983, 1999.
20. Gazouli M, Koundourakis A, Ikonomopoulos J, et al. CARD15/ NOD2, CD14, and toll-like receptor 4 gene polymorphisms in Greek patients with sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 23:23-29, 2006. (Pubitemid 44259206)
21. Hauber HP, Gholami D, Meyer A, et al. Increased interleukin-13 expression in patients with sarcoidosis. Thorax 58:519-524, 2003. (Pubitemid 36714015)
22. Shigehara K, Shijubo N, Ohmichi M, et al. Increased levels of interleukin-18 in patients with pulmonary sarcoidosis. Am J Respir Crit Care Med 162:1979 -1982, 2000.
23. Scappaticci E, Libertucci D, Bottomicca F, et al. Platelet-activating factor in bronchoalveolar lavage from patients with sarcoidosis. Am Rev Respir Dis 146:433- 438, 1992.
24. Milburn HJ, Poulter LW, Dilmec A, et al. Corticosteroids restore the balance between Th1 and Th2 cytokines and immunoglobulin isotypes to normal in sarcoid lung. Clin Exp Immunol 108:105-113, 1997. (Pubitemid 27140337)